Frequently Asked Questions
This section provides answers to commonly asked questions, helping users find the information they need quickly and easily.
What is the scientific basis for Mitoniq?
Mitoniq is based on established research in photobiomodulation (PBM), pulsed electromagnetic field therapy (PEMF), chronobiology, and the role of mitochondria in health and disease. Mitoniq delivers a unique approach by combining proven biophysical therapies with cutting-edge AI and a novel ‘walking biobank’ model.
How does Mitoniq incorporate scientific expertise?
We work closely with leading researchers, including Prof. Glen Jeffery (UCL), to ensure that our technology is grounded in the latest scientific evidence and best practices. We have designed Mitoniq for flexibility and aim to publish our data regularly. We are also committed to partnering with academic institutions to conduct clinical trials and validate our technology.
Can Mitoniq be used for research purposes?
Yes. Mitoniq is designed to collect and analyse anonymised biodata, which can be used for a variety of research purposes, including studies on sleep, energy metabolism, and the effectiveness of personalised interventions.
What is Mitoniq’s business model?
Mitoniq uses a reward-based subscription model, offering a range of plans to fit different user needs and budgets. This subscription structure builds on the freemium subscription for the token incentive to share data. This model has a low friction entry which enables a greater user base.
What is Mitoniq’s competitive advantage?
Mitoniq has a first-mover advantage in the emerging market for home-based mitochondrial wellness platforms. Our integrated ecosystem, personalised approach, and tokenised rewards create a strong value proposition and a competitive edge.
What is Mitoniq seeking in terms of funding?
Mitoniq is currently seeking $100,000 in pre-seed funding to finalise the MVP, secure IP, and refine the AI engine.
What is Mitoniq’s exit strategy?
Potential exit strategies include acquisition by a larger health tech company, an IPO, or strategic partnerships with insurers or hospitals.
How is Mitoniq aligned with Deep Tech?
Mitoniq aligns with organisations supporting deep tech innovation (e.g. Cicada) that address significant global challenges. By improving metabolic health and empowering individuals to take control of their well-being, Mitoniq has the potential to create a significant social and economic impact.